James C. Czirr
2012
In 2012, James C. Czirr earned a total compensation of $292.2K as Executive Chairman and Director at Galectin Therapeutics, a 91% decrease compared to previous year.
Compensation breakdown
Salary | $212,503 |
---|---|
Other | $79,689 |
Total | $292,192 |
Czirr received $212.5K in salary, accounting for 73% of the total pay in 2012.
Czirr also received $79.7K in other compensation.
Rankings
In 2012, James C. Czirr's compensation ranked 10,197th out of 11,487 executives tracked by ExecPay. In other words, Czirr earned more than 11.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,197 out of 11,487 | 11th |
Division Manufacturing | 3,792 out of 4,253 | 11th |
Major group Chemicals And Allied Products | 1,054 out of 1,198 | 12th |
Industry group Drugs | 806 out of 920 | 12th |
Industry Pharmaceutical Preparations | 617 out of 700 | 12th |
Source: SEC filing on April 8, 2015.
Czirr's colleagues
We found three more compensation records of executives who worked with James C. Czirr at Galectin Therapeutics in 2012.